Tamiflu Cleared For Pediatric Flu Prevention
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche's antiviral oseltamivir is now approved for treatment and prevention of influenza in children, adolescents and adults.
You may also be interested in...
Tamiflu Safety Will Get FDA Committee Review Nov. 27
The Pediatric Advisory Committee will evaluate reported neuropsychiatric and behavioral events from patients taking Roche’s influenza product.
Tamiflu Safety Will Get FDA Committee Review Nov. 27
The Pediatric Advisory Committee will evaluate reported neuropsychiatric and behavioral events from patients taking Roche’s influenza product.
Tamiflu For All Ages: Roche’s Influenza Antiviral Cleared In Europe For Adolescents
European Medicines Agency recommends monitoring of potential psychiatric adverse events associated with oseltamivir but does not feel a warning is warranted.